|
End-of-day quote
Shanghai S.E.
14/01/2026
|
5-day change
|
1st Jan Change
|
|
26.11 CNY
|
+0.12%
|
 |
-1.32%
|
-0.72%
|
|
04/01 |
Tranche Update on Hubei Jumpcan Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 24, 2025.
|
CI
| |
24/11 |
Hubei Jumpcan Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 50 million worth of its shares.
|
CI
| |
24/11 |
Hubei Jumpcan Pharmaceutical Co., Ltd. authorizes a Buyback Plan.
|
CI
| |
28/25/28 |
Jumpcan Pharmaceutical's Q3 Profit Drops 47%, Revenue Falls 33%
|
MT
| |
27/25/27 |
Hubei Jumpcan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025
|
CI
| |
17/25/17 |
Jumpcan Pharma Gets Registration Certificate for Lidocaine Cataplasms
|
MT
| |
25/25/25 |
Hubei Jumpcan Pharmaceutical's Attributable Profit Slides 46% in H1; Shares Fall 4%
|
MT
| |
22/25/22 |
Hubei Jumpcan Pharmaceutical H1 net profit down 45.9% Y/Y
|
RE
| |
22/25/22 |
Hubei Jumpcan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025
|
CI
| |
21/25/21 |
Tranche Update on Hubei Jumpcan Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 23, 2024.
|
CI
| |
21/25/21 |
Cao Fei Completes Partial Tender Offer for Jumpcan Pharmaceutical Shares
|
MT
| |
21/25/21 |
Jumpcan Pharmaceutical Gets Registration Certificate for Masiloxavir Tablets
|
MT
| |
21/25/21 |
Hubei Jumpcan Pharmaceutical Co., Ltd.'s Equity Buyback announced on July 22, 2024, has closed with 914,200 shares, representing 0.1% for CNY 25.01 million.
|
CI
| |
20/25/20 |
Hubei Jumpcan Pharma's trading to resume
|
RE
| |
17/25/17 |
Hubei Jumpcan Pharma's share trade to halt
|
RE
| |
17/25/17 |
Cao Fei completed the acquisition of 0.0018% stake in Hubei Jumpcan Pharmaceutical Co., Ltd. for CNY 0.41 million.
|
CI
| |
08/25/08 |
Jumpcan Gets Approval for Traditional Chinese Drug for Constipation, Stomach Strengthening
|
MT
| |
16/25/16 |
Jumpcan Pharmaceutical Receives Tender Offer Worth 9.45 Billion Yuan
|
MT
| |
16/25/16 |
Cao Fei made an offer to acquire 38.2% stake in Hubei Jumpcan Pharmaceutical Co., Ltd. for CNY 8.7 billion.
|
CI
| |
28/25/28 |
Hubei Jumpcan Pharmaceutical Co., Ltd. announces Annual dividend, payable on June 30, 2025
|
CI
| |
25/25/25 |
Hubei Jumpcan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025
|
CI
| |
02/25/02 |
Tranche Update on Hubei Jumpcan Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 23, 2024.
|
CI
| |
12/25/12 |
Jumpcan Pharma's Unit Gets Registration Certificate for Sitafloxacin Granules
|
MT
| |
14/25/14 |
Jumpcan Pharma's Unit Gets Nod for Roxadustat Capsules' Registration
|
MT
| |
04/25/04 |
Tranche Update on Hubei Jumpcan Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 23, 2024.
|
CI
|
No results for this search Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
| 
